Trial Profile
A Phase II Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 23 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.